Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension (Q44473667)

15 June 2018

title

Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension (English)

1 reference

15 June 2018

6

Darren B Taichman

1 reference

15 June 2018

7

Steven M Kawut

1 reference

15 June 2018

author name string

Nicole B Gabler

1

1 reference

15 June 2018

Benjamin French

2

1 reference

15 June 2018

Brian L Strom

3

1 reference

15 June 2018

Ziyue Liu

4

1 reference

15 June 2018

Harold I Palevsky

5

1 reference

15 June 2018

Scott D Halpern

8

1 reference

15 June 2018

language of work or name

English

0 references

publication date

22 September 2011

1 reference

15 June 2018

published in

Chest

1 reference

15 June 2018

volume

141

1 reference

15 June 2018

issue

1

1 reference

15 June 2018

page(s)

20-26

1 reference

15 June 2018

The estrogen paradox in pulmonary arterial hypertension

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Factors associated with racial differences in myocardial infarction outcomes

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Determinants of right ventricular ejection fraction in pulmonary arterial hypertension

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Use of multiple imputation in the epidemiologic literature

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Does size matter? Clinical applications of scaling cardiac size and function for body size

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Power for tests of interaction: effect of raising the Type I error rate

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Surrogate end points in pulmonary arterial hypertension: assessing the response to therapy

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Epidemiology of pulmonary arterial hypertension

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS/OPTN database analysis

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Treating individuals 3: from subgroups to individuals: general principles and the example of carotid endarterectomy

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Sitaxsentan therapy for pulmonary arterial hypertension

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

16 June 2018

Endothelin antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Failure of medical therapy in pulmonary arterial hypertension. Is there an alternative diagnosis?

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Increased mortality in African Americans with idiopathic pulmonary arterial hypertension

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

New predictors of outcome in idiopathic pulmonary arterial hypertension

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Plasma endothelin-1 release during acute stress: role of ethnicity and sex.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5991545

Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension

15 August 2018

1 reference

12 December 2020

Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan

1 reference

12 December 2020

Reporting clinical trial results to inform providers, payers, and consumers

1 reference

12 December 2020

Influence of sex hormones on plasma endothelin levels

1 reference

12 December 2020

Bosentan therapy for pulmonary arterial hypertension

1 reference

12 December 2020

Identifiers

DOI

10.1378/CHEST.11-0404

1 reference

15 June 2018

PMCID

5991545

1 reference

15 June 2018

PubMed ID

21940766

1 reference

15 June 2018